CellWell record HH-126008
Dietary sulforaphane in cancer chemoprevention: epigenetic regulation and PRMT5-MEP50 complex inhibition-a systematic review
Ping Yan; Changfeng Sun; Cunliang Deng
2026
In plain language
This systematic review of 118 studies found a phase II trial in which 12 months of sulforaphane supplementation reduced bronchial Ki-67 proliferation by 20% in high-risk former smokers, versus a 65% increase with placebo.
- Evidence
- Established
- Design
- Systematic review
Cite this record: https://thecellwell.org/studies/HH-126008
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.